Schizophrenia

CLINICAL_TRIALS trial_result · 2021-08-10

Clinical Trial Update: Motivation and Skills Support (MASS) [NA]

Clinical trial update for the MASS study (K03404219) completed; results posted in 2021.

CLINICAL_TRIALS trial_result · 2021-08-06

Clinical Trial Update: Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial [Phase 3]

A phase 3 randomized controlled trial comparing Insight Enhancement Program to Metacognitive Training for psychosis in schizophrenia spectru…

CLINICAL_TRIALS trial_result · 2021-08-05

Clinical Trial Update: Pharmacologic Modulation of Hippocampal Activity in Psychosis [Phase 2]

Phase 2 trial investigating pharmacologic modulation of hippocampal activity in schizophrenia/psychosis; study terminated with posted result…

CLINICAL_TRIALS trial_result · 2021-08-04

Clinical Trial Update: Cognitive Behaviour Therapy for Voices and Dissociation [Phase 2]

Phase 2 trial update for cognitive behavioral therapy targeting voices and dissociation in schizophrenia and related conditions; study compl…

CLINICAL_TRIALS trial_result · 2021-07-27

Clinical Trial Update: Sulforaphane to Reduce Symptoms of Schizophrenia [Phase 2]

Phase 2 clinical trial evaluating sulforaphane for reducing symptoms in schizophrenia and schizoaffective disorder has completed with result…

CLINICAL_TRIALS trial_result · 2021-07-21

Clinical Trial Update: A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia [Phase 3]

Phase 3 long-term safety and tolerability study of ALKS 3831 in adults with schizophrenia completed; results posted.

CLINICAL_TRIALS trial_result · 2021-07-13

Clinical Trial Update: Improving Visual Attention in Schizophrenia [NA]

Completed clinical trial investigating improving visual attention in schizophrenia and schizoaffective disorder; results posted in 2021.

CLINICAL_TRIALS trial_result · 2021-07-13

Clinical Trial Update: Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia [NA]

A completed clinical trial study addressing negative symptoms and community engagement in veterans with schizophrenia and serious mental ill…

CLINICAL_TRIALS trial_result · 2021-07-08

Clinical Trial Update: Remediation of Auditory Recognition in Schizophrenia With tDCS [NA]

Completed clinical trial investigating remediation of auditory recognition in schizophrenia using transcranial Direct Current Stimulation (t…

CLINICAL_TRIALS trial_result · 2021-07-07

Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone [Phase 4]

Phase 4 trial evaluating safety, tolerability, pharmacokinetics, and efficacy of 180 mg subcutaneous risperidone following 6 mg oral risperi…

CLINICAL_TRIALS trial_result · 2021-07-07

Clinical Trial Update: A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia [Phase 2]

Phase 2 study evaluating ABT-126 for cognitive deficits in schizophrenia has completed.

CLINICAL_TRIALS trial_result · 2021-07-07

Clinical Trial Update: A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia [Phase 2]

Phase 2 trial evaluating ABT-126 for cognitive deficits in schizophrenia has completed.

CLINICAL_TRIALS trial_result · 2021-06-15

Clinical Trial Update: Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia [Phase 4]

Phase 4 clinical trial evaluating weekly exenatide injections as an adjunctive treatment for schizophrenia and schizoaffective disorder.

CLINICAL_TRIALS trial_result · 2021-05-25

Clinical Trial Update: Treating Smokers With Mental Illness [Phase 2]

Phase 2 clinical trial assessing treatments for smoking cessation in individuals with mental illness; study completed with posted results in…

CLINICAL_TRIALS trial_result · 2021-05-24

Clinical Trial Update: Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients [Phase 4]

Phase 4 trial update on adjunctive use of flupentixol (Fute) in patients with schizophrenia treated with multi-acting receptor-targeted anti…

CLINICAL_TRIALS trial_result · 2021-05-20

Clinical Trial Update: Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia [Phase 2]

A Phase 2 clinical trial evaluating the safety, tolerability, and efficacy of Evenamide for chronic schizophrenia has completed.

CLINICAL_TRIALS trial_result · 2021-05-05

Clinical Trial Update: Boost rTMS for Auditory Verbal Hallucinations [NA]

Clinical trial update for rTMS in auditory verbal hallucinations associated with schizophrenia; study is terminated with results posted.

CLINICAL_TRIALS trial_result · 2021-04-28

Clinical Trial Update: Pan European Collaboration on Antipsychotic Naïve Schizophrenia II [Phase 4]

Phase 4 clinical trial update on antipsychotic naïve schizophrenia from a pan-European collaboration; study completed.

CLINICAL_TRIALS trial_result · 2021-04-13

Clinical Trial Update: A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia [Phase 2, Phase 3]

This clinical trial update reports results from a long-term Phase 2/3 study of MP-214 in adults with chronic-phase or elderly schizophrenia,…

CLINICAL_TRIALS trial_result · 2021-04-13

Clinical Trial Update: A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia [Phase 2, Phase 3]

Long-term Phase 2/3 study of MP-214 in schizophrenia; results have been posted.